VYNE Therapeutics Inc

-0.04 (-3.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)60.86M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.78 Million
Adjusted EPS-$0.30
See more estimates
10-Day MA$1.28
50-Day MA$1.60
200-Day MA$4.63
See more pivots

VYNE Therapeutics Inc Stock, NASDAQ:VYNE

520 US Highway 22, Suite 204, Bridgewater, New Jersey 08807
United States of America
Phone: +1.800.755.7936
Number of Employees: 106


VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company is headquartered in Bridgewater, NJ.